We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Huntleigh Diagnostics

Featured Products: More products

Download Mobile App





Huntleigh Presents Innovative Solutions in Vascular Care, Fetal and Patient Monitoring at MEDICA 2021

By HospiMedica International staff writers
Posted on 18 Nov 2021
Print article
Image: Huntleigh at MEDICA 2021 (Photo courtesy of Huntleigh Healthcare Ltd.)
Image: Huntleigh at MEDICA 2021 (Photo courtesy of Huntleigh Healthcare Ltd.)

Huntleigh Healthcare Ltd. (Wales, UK), a member of the Arjo family, presented its innovative solutions in vascular care, fetal and patient monitoring at MEDICA 2021.

MEDICA, the world's largest annual medical technology trade fair, took place from 15-18 November in Düsseldorf, Germany. At the 2021 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries. At MEDICA 2021, Huntleigh presented its Sonicaid Fetal Doppler product portfolio, which encompasses Sonicaid Digital SR2/SR3 2&3 MHz Waterproof Rate Display Dopplers, Sonicaid SRX Digital Doppler, Sonicaid D920/D930 Waterproof Audio Dopplers, and the Sonicaid FD1/FD3 2&3MHz Waterproof Dopplers.

These high sensitivity handheld Digital Dopplers are intended for general purpose screening of the fetal heart at all stages of pregnancy from as early as 8-10 weeks, right through to labor. The attached probes are waterproof (IPX7) for high sensitivity FHR detection in both normal use and in waterbirth monitoring. The high performance transducer enables reliable detection from early gestation right through to delivery, even on obese patients. In addition, Huntleigh displayed its new range of high sensitivity XS probes that have been designed, calibrated and fine-tuned to provide excellent performance over the widest gestational age and BMI range in all clinical settings.

Huntleigh also showcased its Smartsigns patient monitoring range which is capable of delivering a wide range of monitoring options, ranging from hand held or portable devices. Smartsigns patient monitors can be used to monitor the patient’s basic vital signs, through to advanced modular systems used in many low, medium & high acuity settings throughout all areas of healthcare. Huntleigh particularly highlighted its new SC500 Series vital signs monitor which comes with an integrated Early Warning scoring tool (MEWS & NEWS2), and three level alarms, making it ideal for long COVID measurements and observations.

Huntleigh’s extensive experience in vascular assessment was evident at MEDICA 2021, as the company showcased its technologically advanced range of products to improve the efficiency and effectiveness in vascular diagnosis. Huntleigh displayed its Dopplex Ability Automatic Automatic Ankle Brachial Index (ABI) System which has revolutionized the ABI process and provides automatic, easy, fast and accurate measurements with an immediate printout of results from the integral printer or optional DR4 software package. Also on display was the company’s entire vascular assessment Dopplers & kits product portfolio, including Dopplex D900, Dopplex SD2, Dopplex ABI Kit and Dopplex ATP Kit. Huntleigh also displayed its LymphAssist Professional 12 Chamber Intermittent Pneumatic Compression (IPC) System which has been designed to offer clinicians a multi modal treatment option to manage Lymphoedema and associated conditions.

Related Links:
Huntleigh Healthcare Ltd. 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Hospital Bed
Alphalite
New
Medical-Grade POC Terminal
POC-821

Print article

Channels

Critical Care

view channel
Image: Changes in immune cells can predict patient recovery following out-of-hospital cardiac arrest (Photo courtesy of Adobe Stock)

Activating T Cells Could Improve Neurological Outcomes After Cardiac Arrest

Despite advancements in cardiopulmonary resuscitation (CPR) and improved hospital access, survival rates after out-of-hospital cardiac arrest (OHCA) remain low, with only about 10% of patients surviving.... Read more

Surgical Techniques

view channel
Image: (Left) An image of a 3D-printed material implanted in vivo for 4 weeks. (Right) A photo of coral (Photo courtesy of Dr Zhidao Xia and Jesus Cobaleda)

Revolutionary Coral-Inspired Material for Bone Repair Promotes Faster Healing

Bone defects caused by fractures, tumors, and non-healing injuries are major contributors to disability worldwide. Traditionally, doctors have used either a patient’s own bone (autograft) or donor bone... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.